About 200 reports

  • Biguanides
  • List of major brands of biguanides for diabetes

Global antidiabetics market is expected to reach USD 84.13 billion by 2020. Growing prevalence of diabetes is the primary driver of this market. Growth in prevalence of disease causing lifestyle disorders such as irregular dietary habits and obesity is also expected to boost product demand by triggering incidence rates of target diseases....

  • Antidiabetics
  • Therapy
  • United States
  • Forecast
  • Market Size
  • Global Biguanides Drug Market, By Value
  • Global Biguanides Drug Market ,By Value

Executive Summary A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Fatty Liver Disease Market on the basis of Type (Alcoholic Fatty Liver Disease or ALD), Non Alcoholic Fatty...

  • Digestive System Disorder
  • Healthcare
  • Pathology
  • World
  • Gilead Sciences, Inc.
  • Biguanides and Amidines 46
  • Biguanides and Amidines 98

• The global market for antiseptics and disinfectants reached $6.4 billion and $6.7 billion in 2015 and 2016, respectively. This market is estimated to reach $9.1 billion in 2022 from nearly $7.1 billion in 2017 at a compound annual growth rate (CAGR) of 5.2% for 2017-2022. • Quaternary ammonium compounds as a segment is expected to grow...

  • Antiseptics
  • Infection Control
  • Medical Supply
  • OTC
  • World
  • Biguanide Disinfectants
  • Biguanide Disinfectants Import

This study focuses on China’s Disinfectants industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major...

  • Infection Control
  • Medical Supply
  • China
  • Trade
  • Chengdu Minsheng Disinfectant Co.
  • 2.9.2.2 Biguanides
  • Biguanides Market, 2017-2027

Insulin and Insulin Analogues, DPP-4 Inhibitors, Biguanides, GLP-1 Agonists, Alpha-glucosidases, SGLT-2 Inhibitors, Sulfonylureas and Others The global diabetes drugs market was valued at $49.26bn in 2016 and is projected to grow at a CAGR of 6.1% in the first half of the forecast period.to reach global revenue of $66.29bn in...

  • Therapy
  • World
  • Market Shares
  • Biguanides Drugs
  • Total Biguanides Production and Demand (million Yuan)

This study focuses on China’s Diabetes Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major...

  • Antidiabetics
  • Diabetes
  • Insulin
  • China
  • Demand
  • Biguanide Disinfectants Major Producer and Their
  • Biguanide Disinfectants Sales Volume and Market

China’s demand for Disinfectants has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption...

  • Infection Control
  • China
  • Demand
  • Chengdu Minsheng Disinfectant Co.
  • Wuhan Newland EPM Co.
  • Total Biguanides Production and Demand (million Yuan)
  • Sulfonylurea Production and Demand (million Yuan)

China’s demand for Diabetes Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption...

  • Diabetes
  • Insulin
  • Pharmaceutical
  • China
  • Zhejiang Expressway Co., Ltd.
  • Figure 16: Global Surface Disinfectants Market Size (US$ Mn) and Volume (Tons), by Biguanides, 2015–2024
  • Global Surface Disinfectants Market Size (US$ Mn) and Volume (Tons), by Biguanides, 2015–2024

Global Surface Disinfectant Market: Overview Surface disinfectants are chemical compound products used to deactivate or destroy microorganisms from environmental surfaces such as floors, chairs, bench tops, walls and ceilings. Depending upon their chemical composition, they can be segmented into several product types such as...

  • Infection Control
  • Medical Supply
  • World
  • Forecast
  • Market Size
  • Biguanides
  • MAJOR PRODUCTS & THEIR SALES IN THE BIGUANIDES DRUG CLASS (USD MILLION) IN 2014

Diabetes is a chronic disease in which there are high levels of sugar in the blood. The World Diabetes Foundation estimates that there will be 438 million people with diabetes by the year 2030. Oral anti-diabetics were the leading category of drugs in 2014 and showed a growth rate of 6.3% from the total global sales. The total sales for insulin...

  • Antidiabetics
  • Diabetes
  • Insulin
  • Pharmaceutical
  • United States
  • T2D TREATMENTS
  • 12.4.1 DIAGNOSED T2D PATIENTS

PharmaPoint: Type 2 Diabetes - Global Drug Forecast and Market Analysis to 2026 Summary Type 2 diabetes (T2D) is a chronic disease characterized by insulin resistance and pancreatic ?-cell failure, with an underlying genetic predisposition heavily influenced by diet and lifestyle (Stumvoll et al., 2010). It is well...

  • Antidiabetics
  • Endocrine Disease
  • Insulin
  • Therapy
  • Type 2 Diabetes
  • 2.13 Most Antiseptic Formulations Comprise Biguanides and Amidines
  • 2.12 Biguanides and Amidines Enable Enhanced Antimicrobial Functions

Novel Microbicidal Platforms Likely to Transform the Future of Global Consumer Health Healthcare-associated infection (HAI) continues to be a significant global concern, hence there is growing research for developing new antimicrobial platforms that can significantly decrease the risk of microbial infections. While...

  • Antiseptics
  • Infection Control
  • Medical Supply
  • OTC
  • World
  • DIABETES DRUGS MARKET, GLOBAL, GENERIC USAGE ACROSS KEY INDICATIONS, 2017
  • DIABETES DRUGS MARKET, GLOBAL, T1DM AND T2DM PIPELINE BY STAGE OF

Orally administered drugs such as the biguanide metformin are typically used as first-line therapies for T##DM.

  • Antidiabetics
  • Clinical Trial
  • Diabetes
  • Insulin
  • World
  • Market segmentation by drug class
  • NON-INSULIN THERAPIES

About Diabetic Therapeutic The global diabetic therapeutic market is growing at a high pace owing to the increase in the prevalence of diabetes globally. The top countries with high prevalence of diabetes are China, India, the US, Brazil, Russia, Mexico, Indonesia, Egypt, Japan, and Bangladesh. It is estimated that more than...

  • Antidiabetics
  • Diabetes
  • Insulin
  • Pharmaceutical
  • Novo Nordisk Group
  • Biguanides
  • BIGUANIDES MARKET, 2016-2023, ($MILLION)

Diabetes Therapeutics Market by Product [Injectables (Insulin, Glucagon-like Peptide-1 (GLP-1) Receptor Agonists, and Amylinomimetic Drugs) and Oral-antidiabetic Drugs (OAD) (Biguanides, Sulfonylureas, Thiazolidinediones, Alpha-glucosidase Inhibitors, Dipeptidyl Peptidase IV (DPP-4) Inhibitors, Meglitinides, and Sodium-glucose Cotransporter-2...

  • Antidiabetics
  • Diabetes
  • Therapy
  • World
  • Market Size
  • 2.9.2.2 Biguanides
  • Biguanides Market, 2016-2026

Report Details Treating diabetes – benefit your influence by finding new R&D trends and sales prospects Discover the future of antidiabetic medicines. For those treatments, you will receive diabetes market size and revenue projections. You will learn the future potential by exploring research and development pipelines. And you...

  • Therapy
  • World
  • Market Shares
  • Global biocides and disinfectants market by nonoxidizing chemicals segment

You can easily book an appointment with one online.

  • Biocide
  • Infection Control
  • Akzo Nobel N.V.
  • Clariant AG
  • Dow Chemical Company
  • Apr 24, 2018: Organogenesis Showcases New Product Offerings and Research at SAWC Spring 2018
  • ADVANCED MEDICAL ENTERS INTO LICENSING AGREEMENT WITH ORGANOGENESIS

GlobalData Organogenesis Inc' s, deal volume increased from one medical equipment deal in 2016 to three medical equipment deals in 2017.

  • Medical Device
  • Medical Equipment
  • Medical Supply
  • United States
  • Organogenesis, Inc.
  • 2.11.1.1 Biguanides
  • 3.2 Biguanides

Type 2 Diabetes Mellitus Therapeutics in Asia-Pacific Markets to 2021 - Increasing Usage of Newer Therapies and Expanding Treatment Population to Encourage Robust Growth Summary Diabetes mellitus is a group of metabolic diseases characterized by chronic hyperglycemia - high blood glucose levels - that results from defects...

  • Antidiabetics
  • Clinical Trial
  • Pharmaceutical
  • Therapy
  • Novo Nordisk Group
  • Not disclosed
  • ACELITY

IT UTILIZES PURIFIED NATIVE COLLAGEN MATRIX EMBEDDED WITH THE ANTIMICROBIAL POLYHEXAMETHYLENE BIGUANIDE.

  • Molecular Biology
  • Tissue Engineering
  • MiMedx Group, Inc.
  • Organogenesis, Inc.
  • Zimmer Biomet Holdings, Inc.
  • LIST OF ABBREVIATIONS
  • ANTIMICROBIAL TEXTILES MARKET SIZE, BY SYNTHETIC ORGANIC COMPOUNDS, 2014-2026 (USD MILLION)

“Increasing demand from healthcare industry and rising awareness towards health and hygiene to drive the antimicrobial textiles market” The antimicrobial textiles market is estimated to be valued at USD 527.9 million in 2016 and is projected to reach USD 1,076.1 million by 2026, at a CAGR of 7.4% from 2016 to 2026. Growth of the...

  • Materials
  • Textile
  • World
  • Market Size
  • Dow Chemical Company
  • 13.4 ANTIMICROBIAL TEXTILES MARKET, BY AGENTS
  • LIST OF ACRONYMS

Polybiguanides are polycationic amines consisting of repeated units of cationic biguanide seperated by aliphatic chains Polyhexamethylene biguanide, also known as polyhexanide and polyaminopropyl biguanide, is one of the most popular biguanide based polym

  • Fabric
  • Materials
  • Textile
  • Thermoplastic
  • Market Size
  • BIGUANIDES 29
  • Biguanides 146

Use this report to: - Analyze the market for drugs used in the treatment of diabetes, it's technology and the industry as a whole - Identify important trends and provide sales forecasts by product categories and major country markets through 2021 - Study epidemiological data, projections and information on R&D trends, and...

  • Chronic Disease
  • Diabetes
  • Pathology
  • World
  • Small Molecule to Agonize GPR119 for Type 2 Diabetes

The molecules developed by companies in Phase II, Phase I, Preclinical and Discovery stages are ##, ##, ## and ## respectively.

  • Molecular Diagnostic
  • Pharmaceutical
  • Therapy
  • Type 2 Diabetes
  • Product Initiative
  • Section 2 - Company Analysis
  • Sumitomo Dainippon Pharma Co Ltd - SWOT Analysis

In April, DSP submitted an application for SUREPOST, for the additional indication of combination therapy with thiazolidinediones and with biguanides.

  • Pharmaceutical
  • Japan
  • United States
  • Company Financials
  • Sumitomo Dainippon Pharma Co., Ltd.
  • PRODUCTS and SERVICES
  • 8.3 MEDTRONIC PLC

The dressings are made of an open-cell polyurethane foam and are impregnated with ##. ##% Polyhexamethylene Biguanide (PHMB).

  • Healthcare
  • Wound Care
  • Acelity L.P. Inc.
  • Coloplast Group
  • ConvaTec Inc.
  • SMALL MOLECULE TO AGONIZE GPR119 FOR TYPE 2 DIABETES - DRUG PROFILE

The molecules developed by companies in Phase II, Phase I, Preclinical and Discovery stages are ##, ##, ## and ## respectively.

  • Molecular Diagnostic
  • Pharmaceutical
  • Therapy
  • Type 2 Diabetes
  • Product Initiative
  • DPP-4 inhibitors
  • SEGMENTATION OF GLOBAL TYPE 2 DIABETES DRUGS MARKET BY DRUG CLASS 2015

About Type 2 Diabetes Diabetes, often referred to as diabetes mellitus, is a metabolic disease in which the patients' blood glucose levels remains high. Depending on the cause of development of diabetes, it can be divided into three types: - Type 1 diabetes (or insulin-dependent diabetes mellitus): In this condition, the pancreas...

  • Antidiabetics
  • Diabetes
  • Insulin
  • Type 2 Diabetes
  • Eli Lilly & Co.
  • 4.9.1 Non-Insulin T2DM Therapies
  • Appendix

Metformin is the only biguanide available in the US.

  • Chronic Disease
  • Diabetes
  • Insulin
  • Type 2 Diabetes
  • World
  • 2.8.1 TREATMENT ALGORITHM
  • 3 Marketed Products

THE BIGUANIDE DRUG CLASS CONSISTS OF METFORMIN, PHENFORMIN AND BUFORMIN.

  • Diabetes
  • Pharmaceutical
  • Therapy
  • Novo Nordisk Group
  • Sanofi S.A.